Results 171 to 180 of about 18,018 (235)
MDMA and MDMA-Assisted Therapy
American Journal of PsychiatryMDMA (i.e., 3,4-methylenedixoymethamphetamine), commonly known as "Ecstasy" or "Molly," has been used since the 1970s both in recreational and therapeutic settings. The Food and Drug Administration (FDA) designated MDMA-Assisted Therapy (MDMA-AT) as a Breakthrough Therapy for posttraumatic stress disorder (PTSD) in 2017, and the FDA is requiring an ...
Aaron S, Wolfgang +9 more
openaire +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
2023
Abstract MDMA (3,4-methylenedioxymethamphetamine) was originally synthesized and patented by the Merck chemical company in 1914. It was not explored for human use until the 1970–80s when there were published reports that it could be a useful catalyst to psychotherapy, in part because it often produced reduced anxiety and increased ...
Michael C. Mithoefer, David E. Presti
openaire +1 more source
Abstract MDMA (3,4-methylenedioxymethamphetamine) was originally synthesized and patented by the Merck chemical company in 1914. It was not explored for human use until the 1970–80s when there were published reports that it could be a useful catalyst to psychotherapy, in part because it often produced reduced anxiety and increased ...
Michael C. Mithoefer, David E. Presti
openaire +1 more source
The role of extracellular serotonin and MDMA in the sensitizing effects of MDMA
Behavioural Brain Research, 2022MDMA is a non-selective monoamine releasing stimulant with potent serotonergic effects - a pharmacological effect not typically associated with drugs of misuse or efficacious reinforcers. Nonetheless, MDMA is misused by humans and self-administered by laboratory animals.
Ross, van de Wetering +5 more
openaire +2 more sources